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Super-low dose endotoxinSepsis mortality varies dramatically in individuals of variable immune conditions, with poorly deﬁned mecha-
nisms. This phenomenon complements the hypothesis that innate immunity may adopt rudimentary memory,
as demonstrated in vitro with endotoxin priming and tolerance in cultured monocytes. However, previous
in vivo studies only examined the protective effect of endotoxin tolerance in the context of sepsis. In sharp con-
trast, we report herein that pre-conditioning with super-low or low dose endotoxin lipopolysaccharide (LPS)
cause strikingly opposite survival outcomes. Mice pre-conditioned with super-low dose LPS experienced severe
tissue damage, inﬂammation, increased bacterial load in circulation, and elevatedmortality when theywere sub-
jected to cecal-ligation and puncture (CLP). This is in contrast to the well-reported protective phenomenon with
CLPmice pre-conditionedwith low dose LPS.Mechanistically, we demonstrated that super-low and lowdose LPS
differentially modulate the formation of neutrophil extracellular trap (NET) in neutrophils. Instead of increased
ERK activation and NET formation in neutrophils pre-conditioned with low dose LPS, we observed signiﬁcantly
reduced ERK activation and compromised NET generation in neutrophils pre-conditioned with super-low dose
LPS. Collectively, ourﬁndings reveal amechanismpotentially responsible for thedynamic programmingof innate
immunity in vivo as it relates to sepsis risks.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sepsis is a life-threatening syndrome commonly experienced by
patients in critical care units. Sepsis syndromeposes a particular concern
for people with prior health conditions, a phenomenon often referred as
“second-hit” or “pre-conditioning” (Rocksen et al., 2004; Wang et al.,
1998). Prior immune conditionmay have a critical impact on the clinical
outcome of sepsis. Despite extensive past studies, mechanisms contrib-
uting to the alteration of sepsis risks remain poorly understood.
A classic example of innate immunity pre-conditioning ismanifested
in the endotoxin tolerance of innate leukocytes (Morris and Li, 2012).
Most studies regarding cellular responses to endotoxin lipopolysaccha-
ride (LPS) utilized tolerant dosages of LPS (often referred as “low
dose” in the literature) (N10 ng/mL in vitro culture, N1 μg/mouse or
N50 μg/kg body weight in vivo injection). Low dose LPS (L-LPS) causes
robust induction of pro-inﬂammatory mediators in monocytes/
macrophages through the Toll-Like-Receptor 4 (TLR4) pathway (Kawai
and Akira, 2007). Shortly after the initial wave of expression, host leuko-
cytes develop a state of “endotoxin tolerance”, in which the expressionsSciences, Virginia Polytechnic
shington Street, Blacksburg, VA
. This is an open access article underof pro-inﬂammatorymediators are suppressed (Henricson et al., 1993; Li
et al., 2000; West and Heagy, 2002). Endotoxin tolerance serves as a
compensatory mechanism for the resolution of inﬂammation (Jacinto
et al., 2002; Medvedev et al., 2002). Based on the tolerance concept, en-
dotoxin has been employed experimentally to elicit a protective mecha-
nism for subsequent inﬂammatory conditions that include ischemia
injury and sepsis (Kopanakis et al., 2013; Meng et al., 1997).
Mechanistically, the prior conditioning with L-LPS not only reduces
tissue inﬂammation through inducing tolerance, but also boosts bacteri-
al killing activities of neutrophils partly through increasing the forma-
tion of neutrophil extra-cellular trap (NET) (Landoni et al., 2012).
NETs released by neutrophils not only traps and clears bacteria, but
may also degrade inﬂammatory mediators and therefore limit further
exacerbation of inﬂammation (Campbell et al., 2012). Indeed, individ-
uals with impaired NETosis demonstrate excessive production of in-
ﬂammatory mediators from neutrophils and persistent inﬂammation
(Schauer et al., 2014). NET-deﬁcient mice also develop exacerbated
and chronic inﬂammation that can be reduced by adoptive transfer of
aggregated NETs (Schauer et al., 2014). In the context of sepsis, deple-
tion of neutrophil NETs in vivo results in hyper susceptibility to
polymicrobial sepsis (Meng et al., 2012). Mechanistically, NET forma-
tion in neutrophils may depend upon the activation of the extracellular
signal-regulated kinase (ERK) (Hakkim et al., 2011; Yoo et al., 2014),
and selective inhibition of ERK has been demonstrated to be a potent
suppressor of NETosis (Hakkim et al., 2011). ERK is known to bethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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signal and contribute to endotoxin tolerance in other innate immune
cells (Maitra et al., 2011).
Although LPS tolerance may explain the beneﬁcial and protective
effect of L-LPS pre-conditioning in the context of sepsis, it may not
reconcile increased sepsis mortality often observed in patients with
prior health conditions. In sharp contrast, emerging studies hint at an
intriguing connection between subclinical super-low levels of circulat-
ing bacterial endotoxin lipopolysaccharide (SL-LPS) (b100 pg/mL) in
humans with adverse health conditions and/or life styles such as
chronic infections, aging, chronic smoking and drinking (Ancuta et al.,
2008; Cani et al., 2008; Goto et al., 1994; Lira et al., 2010; Rao, 2009;
Szeto et al., 2008; Wiedermann et al., 1999). Compromised mucosal
barriers, altered commensalmicrobiota, and vasculature leakage collec-
tively contribute to the mild elevation of plasma endotoxin in these
individuals. We and others have previously shown that super-low
dose LPS (SL-LPS, ~1–100 pg/mL in vitro, 100 pg–10 ng/mouse or
5 ng–0.5 μg/kg body weight in vivo injection) “primes” monocytes/
macrophages for a more robust response to a secondary LPS challenge,
a phenomenon known as the “Shwartzman reaction” (Deng et al., 2013;
Henricson et al., 1993; Hirohashi and Morrison, 1996; Zhang and
Morrison, 1993a). At the molecular levels, we demonstrate that SL-LPS
preferentially clears away the compensatory anti-inﬂammatory signals
in monocytes/macrophages, in sharp contrast to the effect of low dose
LPS (Deng et al., 2013; Maitra et al., 2012). The dynamic pathway-
switching in monocytes/macrophages induced by varying dosages of
LPS may underlie the “pre-conditioning” of innate immunity and “rudi-
mentary” innate memory (Fu et al., 2012).
Despite this intriguing connection, pre-conditioning with SL-LPS in
the context of sepsis mortality has never been studied. Thus, we tested
the hypothesis that SL-LPS pre-conditioning may exacerbate, instead of
alleviate sepsis mortality in vivo. We employed the classical cecal liga-
tion and puncture (CLP) model of polymicrobial sepsis, and examined
mortality, tissue inﬂammation, and neutrophil bacterial killing in mice
pre-conditioned with either low dose (50 μg/kg body weight) or
super-low dose (5 ng/kg body weight) LPS. Another feature of this
study involves the emerging concept of innate leukocyte programming.
Although emerging studies reported the differential programming of
monocytes/macrophages by SL-LPS and L-LPS (Morris et al., 2015), no
data is available with regard to whether neutrophil, a key innate leuko-
cyte in the context of sepsis, could be dynamically programmed by SL-
LPS and L-LPS. Our study reveals that pre-conditioning with super-low
dose LPS signiﬁcantly increased CLP sepsis mortality and tissue inﬂam-
mation, through reducing neutrophil NETosis and bacterial killing.
Counter-intuitively, we observed that SL-LPS signiﬁcantly suppressed
ERK activation in neutrophils, instead of activating ERK. Taken together,
our study reveals programming dynamics of innate immunity in vivo by
SL-LPS.
2. Materials and Methods
2.1. Mice
Inbred C57 BL/6mice between the ages of 8 and 12weeks were used
for experimentation. The mice were bred and housed in our pathogen-
free, limited access, ultra-barrier facility with a 12-h light-dark cycle. All
experiments describedwere performed in adherence to theNational In-
stitutes of Health guidelines on the use of experimental animals, and ap-
proval was obtained from the Institutional Animal Care and Use
Committee (IACUC) of Virginia Polytechnic Institute and State
University.
2.2. Reagents
Fluorescein isothiocyanate (FITC) conjugated anti-mouse Ly6G/Ly6C
(Gr-1) antibody and Streptavidin conjugated anti-mouse CXCR2antibody were from Biolegend (San Diego, CA). Anti-citrullinated
histone H3 antibody was from Abcam (Cambridge, MA) and the
anti-citrullinated Histone H4 antibody was from Millipore (Billerica,
MA).
2.3. Cecal Ligation and Puncture (CLP)
CLP were performed as previously described (Toscano et al., 2011).
Brieﬂy, anesthetized mice (male, 8 weeks old) with approved protocol
from the institutional IACUC committeewere operated at the abdomen,
with the cecum being identiﬁed, exposed, and ligated with a 3-0 silk
suture at its base below the ileocecal junction. The antimesenteric bor-
der of the cecum was punctured once with a 21-gauge needle, and the
cecum was gently squeezed to extrude a small amount of stool. The
cecum was returned to the abdomen, which was closed in two layers
with 3–0 silk by means of running sutures. Sham controls were per-
formed with ligation but without puncture. After surgery, mice were
resuscitated with 1.0 mL of saline including Buprenorphine (0.05 mg/kg
in 1 mL saline) given by subcutaneous injection. The mice were moni-
tored and recorded every 4 h for mortality for four days in a blinded
fashion by observers.
2.4. Bacterial Counts in Blood
The bacterial count was determined as previously described
(Godshall et al., 2002). In brief, mice were sacriﬁced at various days
post-CLP. Aliquots of serial dilutions were placed on agar dishes (Difco
Laboratories) and incubated at 37 °C. Colony Forming Units (CFU)
were analyzed after 24 h. The results were expressed as log of CFU per
mL or CFU × 103/mL of blood.
2.5. Pathology
For routine histologic analysis, frozen livers (1 mm × 5 mm), lungs
(left lobe) and kidneys (whole kidney) were sectioned, stained with
H&E. PMN were counted in a blinded and standardized fashion by
light microscopy (Axiovert 40, Zeiss, Goettingen, Germany). Brieﬂy, a
micrometer ocular (×20) was used to count PMN in 6 different visual
ﬁelds of each section. The histologic grading of liver injury was evaluat-
ed by the following score scale of values: 1). Inﬁltration of inﬂammatory
cells (numbers/ﬁeld): 1: 0–9; 2: 10–19; 3: 20–29; 4: 30–39; 5: 40 and
over; 2). Hepatocyte degeneration (%): 1: 0–9; 2: 10–29; 3: 30–49; 4:
50–69; 5: 70 and over; and 3). Hepatocyte necrosis (%): 1: 0–9; 2: 10–
19; 3: 20–29; 4: 30 and over. For the scoring of lung damage, inﬁltration
of inﬂammatory cells, vascular congestion and interstitial edema were
evaluated. For kidney damage, inﬁltration of inﬂammatory cells, necro-
sis, degeneration of tubular cells and glomerulus damage were evaluat-
ed. All parameterswere evaluated by the following score scale of values:
0, absent; 1, mild; 2, moderate; and 3, severe (Meng et al., 1997). All
histopathological evaluations were done in a blinded fashion by an in-
dependent pathologist.
2.6. NET Formation Through Flow Cytometry and Immunoﬂuorescence
For in vivo analyses, mice were administrated with super-low dose
(5 ng/kg body weight) or low dose (50 μg/kg body weight) LPS through
i.p. injection. After 24 h, splenocytes were harvested and stimulated
with PMA (50 nM) for 3 h. Cells were ﬁxed and permeabilized with
BD Phosﬂow™ buffer (BD Biosciences, San Jose, CA). Anti-citrullinated
Histone H4 antibody (Millipore, Billerica, MA) was labeled with Alexa
Fluor 647 using Zenon™ labeling kit (Life Technologies, Grand Island,
NY), and then was used to stain splenocytes together with anti-Ly6G
and anti-CD11b antibodies (BioLegend, SanDiego, CA). For in vitro stud-
ies, bone marrow cells from C57 BL/6 mice were cultured with G-CSF
(100 ng/mL) in the presence of super-low dose (100 pg/mL) or higher
dose (1 μg/mL) LPS for 3 days, with fresh LPS added to the cell cultures
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the cell culture. After stimulation with Phorbol myristate acetate
(PMA, 50 nM) for 3 h, cells were ﬁxed, permeabilized and stained
with Alexa Fluor 647 labeled anti-Histone H4 (citrulline 3) antibody
together with anti-Ly6G and anti-CD11b antibodies. The samples were
then analyzed by FACSCanto II (BD Biosciences). The data were proc-
essed by FACSDiva (BD Biosciences), or Flow Jo (Tree Star, Ashland,
OR). For immunoﬂuorescence analyses, peritoneal cells were har-
vested from PBS or LPS conditioned-mice at indicated time point
post-CLP, and spun on glass slides through cytospin. Neutrophils
were co-stained with antibodies against Ly6G and citrullinated His-
tone H3. DAPI was used to stain cell nucleus. Samples were analyzed
with ﬂuorescence microscopy.
2.7. Determination of Protein Phosphorylation
Bone marrow cells from C57 BL/6 mice were cultured with G-CSF
(100 ng/mL) in the presence of super-low dose (100 pg/mL) or higher
dose (1 μg/mL) LPS, with fresh LPS added to the cell culture every
24 h. In some experiments, Tauroursodeoxycholic acid (TUDCA,
0.5 mM) was also added to the cell cultures. After 3 h or 3 days, cells
were then ﬁxed, permeabilized and stained with either anti-pERK1/2
(T204/Y202, eBioscience, San Diego, CA) or anti-pJNK (T183/Y185, BD
Biosciences) antibody togetherwith anti-Ly6G and anti-CD11b antibod-
ies. The samples were analyzed by FACSCanto II. The data were proc-
essed by FACSDiva, or Flow Jo. Whole protein lysates were also
prepared for Western blot analyses.
2.8. ELISA of Cytokines
Plasma samples were collected from the peripheral blood. TNF-α
and CXCL1/KC/GROα levels were measured by enzyme-linked im-
munosorbent assay (ELISA) using ELISA Kit from eBioscience and
RayBiotec, respectively.
2.9. Chemotaxis Assays
Chemotaxis of neutrophils was measured with 48-well micro-
chambers and polycarbonate ﬁlters (5 μm pore size) (NeuroProbe,
Cabin John, MD) as described (Tancevski et al., 2014). The results
were expressed as the mean ± SEM of the chemotaxis index (CI),
representing the fold increase in the number of migrated cells in
response to chemo-attractants over spontaneous cell migration (to con-
trol medium).
2.10. Statistical Analysis
Statistical analysis was performed with Prism software (GraphPad
Software, La Jolla, CA). Values were expressed asmeans± SEM. The sig-
niﬁcance of the differences was assessed by Student’s t test or one-way
ANOVA where appropriate. p b 0.05 was considered statistically signiﬁ-
cant. The mortality studies were assessed with log rank test with
p b 0.05 considered as signiﬁcant.
3. Results
3.1. Pre-conditioning With Super-low LPS Exacerbates Sepsis Mortality
To examine the impact of super-low LPS pre-conditioning on
sepsis mortality, we used the murine model of cecal ligation and
puncture (CLP). As a control, we simultaneously studied the effect
of low dose LPS. In consistent with previous reports (Kopanakis
et al., 2013; Landoni et al., 2012), mice injected i.p. with L-LPS
(50 μg/kg body weight) 24 h before CLP exhibited signiﬁcantly im-
proved survival as compared to sham mice or mice injected with
PBS controls (Fig. 1A). In sharp contrast, we documented that miceinjected with SL-LPS (5 ng/kg body weight) displayed signiﬁcantly
reduced survival as compared to PBS controls (Fig. 1A).
Next, we examined bacterial loads in the blood after CLP. As shown
in Fig. 1B, bacterial counts were signiﬁcantly increased in the peripheral
blood of CLP mice pre-conditioned with 5 ng/kg body weight SL-LPS. In
contrast, bacterial counts were signiﬁcantly reduced in the peripheral
blood of CLP mice pre-conditioned with 50 μg/kg body weight L-LPS
(Fig. 1C).
We further examined selected inﬂammatory markers in circula-
tion. In consistent with previous ﬁndings (Kopanakis et al., 2013;
Landoni et al., 2012), CLP mice pre-conditioned with tolerant dose
(50 μg/kg bodyweight) L-LPS had signiﬁcantly reduced levels of plasma
TNF-α andKC as compared to CLPmice pre-conditionedwith either PBS
or priming-dose (5 ng/kg body weight) SL-LPS (Fig. 1D). In sharp con-
trast, we documented that CLP mice pre-conditioned with priming SL
dose (5 ng/kg body weight) LPS had a signiﬁcant and persistent eleva-
tion of plasma levels of TNF-α and KC (CXCL1) as compared to other
two groups. Collectively, these data reveal that the mice pre-
conditioned with SL-LPS (5 ng/kg body weight) displayed signiﬁcantly
reduced survival, increased blood bacteria counts and increased sys-
temic inﬂammatory responses upon septic challenge. This is sharp con-
trast to the protective effects observed in mice pre-conditioned with
tolerant L-LPS.
3.2. Elevated Tissue Injuries in CLP Mice Pre-conditioned With Super-low
LPS
Given the opposite survival outcomes, we further examined tissue
damage and inﬂammation in vital organs. Consistent to previous
reports, the disease scores and neutrophil inﬁltrations in kidney, liver,
and lungwere signiﬁcantly lower in CLPmice pre-conditionedwith tol-
erant L-LPS (Fig. 2A–C). In contrast, we observed signiﬁcantly elevated
disease scores and neutrophil inﬁltrations in kidney, liver and lung
from CLP mice pre-conditioned with SL-LPS (Fig. 2A–C). The elevated
neutrophil levels in vital organs are consistent with our above data
that the circulating chemokine CXCL1/KC levels are highest in the CLP
mice pre-conditioned with SL-LPS. On the other hand, the reduced neu-
trophil levels and reduced tissue damages in CLP mice pre-conditioned
with tolerant L- LPS are correlatedwith reduced CXCL1/KC levels, and in
line with previous studies (Kopanakis et al., 2013; Landoni et al., 2012).
3.3. Differential Modulation of Neutrophil CRXCR2 Expression by Super-low
and Low Dose LPS
Neutrophil inﬁltrations in vital organs are not only affected by the
circulating levels of inﬂammatory chemokines such as CXCL1/KC, but
also by the surface expression levels of chemokine receptors such as
CXCR2. Indeed, CXCR2 was shown to play a critical role in CLP-related
organ injury and mortality, and that tolerant dose LPS potently leads
to a dramatic reduction in cellular levels of CXCR2 in neutrophils, corre-
lating with reduced neutrophil inﬁltration in vital organs (Ness et al.,
2003; Sabroe et al., 2003). We conﬁrmed this ﬁnding as shown in
Fig. 3. The levels of CXCR2 expression on peritoneal neutrophils harvest-
ed from CLP mice pre-conditioned with L-LPS were signiﬁcantly re-
duced as compared to CLP mice pre-conditioned with PBS (Fig. 3A–B).
In contrast, we observed that SL-LPS failed to signiﬁcantly reduce the
expression levels of CXCR2 (Fig. 3A–B). We further tested the in vitro
modulation of CXCR2 by LPS. As shown in Fig. 3C–D, only L-LPS led to
signiﬁcant reduction of CXCR2 expression in cultured neutrophils as
measured by ﬂow cytometry. In sharp contrast, SL-LPS failed to signiﬁ-
cantly alter the expression levels of CXCR2. Coupled with the fact the
SL-LPS pre-conditioning leads to a primed induction of CXCL1/KC, the
CXCR2 ligand, these results may explain the increased inﬁltration of
neutrophils in vital tissues such as liver and kidney in CLP mice pre-
conditioned with SL-LPS.
Fig. 1. Opposite sepsis outcomes in mice pre-conditioned with super-low and low dose LPS. (A). WT mice (male, 8 weeks old) were pre-conditioned through i.p. injection of either PBS
(30 mice), super-low dose (SL-LPS, 5 ng/kg) LPS (30 mice), or low-dose (L-LPS, 50 μg/kg) LPS (30 mice). CLP were performed 1 d post-pre-conditioning, and mortality was closely mon-
itored every 4 h for 4 d. *p b 0.05. (B). Blood samples were collected frommice 2 d post-CLP. Bacteria were cultured, counted and plotted. The results were expressed as colony-forming
units (CFU)/mL. *p b 0.05, N=11mice per group. (C). Blood sampleswere collected frommice 4 d post-CLP. Bacteriawere cultured, counted andplotted. The resultswere expressed as log
of colony-forming units (CFU)/mL. *p b 0.05, **p b 0.01. N=4mice per group, the data were representative from 3 independent experiments. (D). Blood collected at days 0, 1, and 4 post-
CLP were used to measured plasma levels of TNF-α and KC through ELISA. P: PBS; SL: SL-LPS; L: L-LPS *p b 0.05; **p b 0.01. N = 4 mice per group, the data were representative from 3
independent experiments.
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In addition to the differential modulation of inﬂammatory
responses, we also observed differential bacterial loads in the
circulating blood of CLP mice pre-conditioned with super-low and
low dose LPS. Our data suggest that the bacterial killing ability of
neutrophils may be altered in mice pre-conditioned with varying
dosages of LPS. Indeed, it has been reported that pre-conditioning
with L-LPS facilitates neutrophil NET formation, thus favoring bacte-
ria clearance (Landoni et al., 2012). NET is also implicated in the
clearance of inﬂammatorymediators and the reduction of inﬂammation
(Campbell et al., 2012). Thus, we focused our current study to examine
the NET formation. First, we stained the citrullinated Histones in perito-
neal neutrophils, a well-deﬁned marker for NET formation. Consistent
with previous ﬁndings, we observed elevated NET formation in perito-
neal neutrophils from CLP mice pre-conditioned with L-LPS (Fig. 4A).
In contrast, we observed that peritoneal neutrophils from CLP mice
pre-conditioned with SL-LPS failed to have noticeable elevation in NET
formation, as observed under microscopy.
To better examine and quantitate the neutrophil potential of gener-
ating NET, we used ﬂow cytometry to measure neutrophils containing
citrullinated Histones. As shown in Fig. 4B, signiﬁcantly higher per-
centages of neutrophils harvested from mice pre-conditioned with
L-LPS were positive for citrullinated Histones upon ex vivo PMA chal-
lenge, as compared to neutrophils from PBS pre-conditioned mice. In
contrast, signiﬁcantly lower percentages of neutrophils from mice
pre-conditioned with SL-LPS were positive for citrullinated Histones
upon ex vivo challenge with Phorbol myristate acetate (PMA).
We further examined NET formation in cultured neutrophils con-
ditioned with varying dosages of LPS in vitro. Consistent with our
in vivo and ex vivo data, we observed that G-CSF cultured neutrophilstogether with SL-LPS exhibited reduced NET formation triggered by
PMA (Fig. 4C, D). In sharp contrast, cultured neutrophils with L-LPS
had signiﬁcantly elevated NET formation upon further PMA challenge.
Taken together, our data reveal that SL-LPS pre-conditioning dampens,
while L-LPS pre-conditioning potentiates the NET forming potential of
neutrophils both in vitro and in vivo.
3.5. Differential Modulations of JNK and ERK by Super-low and Low Dose
LPS Contribute to Dynamic Modulation of Neutrophil Function
Next, we focused on examining the molecular mechanisms respon-
sible for the opposite regulation of NET formation in neutrophils pre-
conditioned by super-low and low dose LPS. Studies from other systems
suggest that ERK is responsible for NET formation (Hakkim et al., 2011;
Yoo et al., 2014), while recent studies suggest that the c-Jun N-terminal
kinase (JNK) and ERKmay form amutually competitive signaling circuit
(Arany et al., 2004; Bakal et al., 2008; Junttila et al., 2008; Shen et al.,
2003). However, no published study is available with regard to the
potential regulation and involvement of ERK/JNK in NET formation in
neutrophils challengedwith SL-LPS. Based on these clues, we ﬁrst tested
the activation status of JNK and ERK in neutrophils via ﬂow cytometry.
As shown in Fig. 5A and consistent with previous studies, we observed
that neutrophils cultured with 1 μg/mL tolerant dose L-LPS had signiﬁ-
cantly elevated levels of p-ERK. In sharp contrast, we observed that
SL-LPS selectively activated p-JNK accompanied. Counter-intuitively,
we observed a signiﬁcant reduction of p-ERK in cells treated with SL-
LPS. Our data provides evidence that SL-LPS and L-LPS differentially
skew the dynamic signaling circuit within neutrophils.
We further explored a potential intervention strategy in re-balancing
neutrophil responses. Among published studies with existing
small chemical compounds, we noticed the intriguing effects of
Fig. 2. Differential modulation of tissue injuries in CLP mice pre-conditioned with super-low or low dose LPS. Vital organs were collected from CLP mice pre-conditioned with either PBS,
5 ng/kg LPS, or lowdose (50 μg/kg) LPS. (A) Frozen kidney sectionswere stainedwithH&E. G: glomerulus; T: tubular cells; arrow: PMN. Scale bar=50 μm. (B) Frozen lung sections (5 μm)
were stained with H&E. A: Alveolus; B: Bronchiole; V: Blood vessels; arrow: PMN. Scale bar = 50 μm. (C) Frozen liver sections (5 μm) were stained with H&E. Arrow: PMN. Scale bar =
50 μm. Disease scores were evaluated and plotted. *p b 0.05. ***p b 0.001. Data were pooled from three independent experiments.
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Chinese traditional medicine (Engin et al., 2013). TUDCA was shown
to have remarkable beneﬁcial effects in treating wound and injury, as
well as other inﬂammatory conditions (Colak et al., 2008; Engin et al.,
2013). At the biochemical level, TUDCA was shown to suppress JNK
and activate ERK in other cellular systems (Engin et al., 2013; Schliess
et al., 1997). We hypothesize that TUDCA may be able to intervene
the harmful effects of SL-LPS in neutrophils. Indeed, we observed that
co-stimulation of cultured neutrophils with TUDCA and SL-LPS restored
ERK activation and suppressed JNK activation as compared to neutro-
phils treated with SL-LPS alone (Fig. 6A).
Finally, given the promising effects of TUDCA on JNK and ERK in
neutrophils, we further tested its effects on neutrophil NET formation.
As shown in Fig. 6B, co-stimulation of neutrophils with TUDCA and SL-
LPS restored the NET-forming ability of neutrophils as assessed byﬂow cytometry. Taken together, our data reveal that SL-LPS reduces
neutrophil NET formation through suppressing ERK activation. Further,
TUDCA may serve as an effective intervention compound in restoring
neutrophil NET formation, through augmenting ERK activation in neu-
trophils challenged with SL-LPS.
4. Discussion
Collectively, our current study provides a ﬁrst systematic analysis of
in vivo relevance of dynamic innate pre-conditioning in the context of
sepsis (Fig. 7). Mortality risks for sepsis vary dramatically in humans,
and patient conditions prior to septic insult may be a critical contribut-
ing factor. However, previous studies solely examined the potential
beneﬁcial effects of “tolerant” dose L-LPS in animal models of sepsis
(Kopanakis et al., 2013; Landoni et al., 2012). These studies are
Fig. 3.Differential modulation of neutrophil migration by super-low and low dose LPS. (A) CXCR2 expression on the Gr-1+ cell population isolated from the peritoneal lavages ofmice 4 d
post-CLP was analyzed by ﬂow cytometry. Mice were pre-conditioned with either 5 ng/kg (SL-LPS) or 50 μg/kg (L-LPS) 1 d prior to the CLP procedure. (B) Cumulative percentages of
CXCR2+Gr-1+ cells from the peritoneal lavage 4 d post-CLP. Results were expressed as the mean ± SEM, N = 4–5 mice per group as indicated in the ﬁgure. Data were representative
of 3 independently performed experiments. *p b 0.05. All mice used were male and 8–10 weeks old. (C) CXCR2 expression on neutrophils in vitro was analyzed by ﬂow cytometry
after stimulation of indicated LPS concentration. Bone marrow cells were stimulated with either PBS, 100 pg/mL or 1 μg/mL LPS for 3 h. The expression levels of CXCR2 on neutrophils
were quantiﬁed through ﬂow cytometry. *p b 0.05. (D) Cumulative fold change of CXCR2+Gr-1+ cells in vitro after stimulation with LPS. Data represent 3 independently performed ex-
periments. Results were expressed as the mean ± SEM. *p b 0.05.
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tempers the pro-inﬂammatory cytokine storm (Morris and Li, 2012).
Intriguingly, recent studies in humans and mice reveal the presence
of subclinical super-low dose SL-LPS in circulation, potentially responsi-
ble for non-resolving chronic inﬂammation (Sunil et al., 2007; Terawaki
et al., 2010). We and others reported that innate leukocytes can be dy-
namically pre-conditioned to opposite functional states in vitro, with
super-low dose LPS selectively “primes” the expression of pro-
inﬂammatory cytokines (Deng et al., 2013; Zhang andMorrison, 1993b).
Despite the emerging signiﬁcance of dynamic innate immunity
preconditioning or “training”, no existing study is available to address
the pre-conditioning effect of super-low LPS in the context of sepsis.
We have aimed at an integrated study that compares and reconciles
the pre-conditioning effects of both super-low and low dose LPS in sep-
tic mice. Consistent with previous studies, we found that CLP-mice
pretreated with low dose LPS showed reduced mortality, reduced
inﬂammatory responses, diminished injury of vital organs (liver, lung
and kidney), and increased NET formation as well as effective bacterial
clearance. In sharp contrast, we demonstrated that CLP-mice pre-
conditioned with super-low dose LPS displayed increased mortality,
elevated plasma levels of TNF-α and KC, increased neutrophil inﬁltra-
tion in vital tissues, attenuated ability of neutrophil NET formation and
increased circulating levels of bacteria.
Our data providemuch-needed evidence to support the pathological
relevance of super-low dose endotoxemia, and extend the intriguing
dynamics of innate priming and tolerance to an in vivo model of sepsis.
Emerging in vitro studies reveal that innate monocytes may adopt
distinct phenotypes by prior conditioning or “training” with varyingdosages of innate stimulants (Deng et al., 2013; Netea et al., 2011;
Quintin et al., 2012). For example, pre-conditioning with super-low
dose LPS “primes” the expression of selected pro-inﬂammatory media-
tors such as TNF-α and IL-12, while suppressing the expression of iNOS
(Hirohashi and Morrison, 1996). In contrast, pre-conditioning with ele-
vated low dose LPS “tolerizes” the expression of selected genes
(Hirohashi and Morrison, 1996). In consistent with these in vitro stud-
ies, we conﬁrmed the “priming” and “tolerance” effects in vivo, and
demonstrated that pre-conditioning with super-low dose LPS exacer-
bates the levels of TNF-α and KC in CLP-mice. Studies also suggest that
the innate responses to varying dosages of LPS may not ﬁt into the sim-
ple paradigm of priming and tolerance, and hint at more complex adap-
tation proﬁles (Foster et al., 2007). On a separate note, the adaptation
phenomenon to varying dosages of LPS is different as compared to the
traditional M1/M2 concept, in which distinct agonists are required for
the differential activation of M1 (by IFNγ) or M2 (through IL-4)
(Martinez et al., 2008). Similar adaptation paradigm to varying signal
strength may also exists in other immune cell types. For instance, al-
though T helper cells arewell known to adopt different functional states
(Th1, Th2, Th17, Treg) when challenged with distinct combination of
cytokines (Hong et al., 2011), emerging recent study reported that T
helper cell differentiation can also be achieved through varying the sig-
nal strength of the TCR signal (Salmond et al., 2014; van Panhuys et al.,
2014). Collectively, these studies draw serious attention to the issue of
dynamic responses of immune cells when challengedwith varying dos-
ages of the same stimulant.
Our study reveals additional aspects of innate pre-conditioning and
adaptation in neutrophils. Neutrophil is a key innate leukocyte, and
Fig. 4. Differential regulation of NET formation by super-low and low dose LPS. (A) The PMN isolated from the peritoneal lavage 1 d after CLP from the mice pre-conditioned with either
PBS, lowdose LPS (L-LPS), or super lowdose LPS (L-LPS)were spun on the slides.Neutrophilswere stainedwith the anti-mouseGr-1 antibody followedbybiotinylated anti-Rat Ig antibody
and Streptavidin-FITC (green). NETswere stainedwith the anti-citrullinatedHistone H3 antibody followed by the biotinylated goat anti-rabbit Ig antibody and Streptavidin-PE (red). DNA
was stainedwith DAPI (blue).White arrow: NET. Scale bar=30 μm. (B) C57 BL/6micewere i.p. injectedwith super-low dose (5 ng/kg) or low dose (50 μg/kg) LPS. After 24 h, splenocytes
were harvested and re-stimulatedwith PMA (50 nM) for 3 h. The levels of histone H4 (citrulline 3) within CD11b+/Ly6G+ neutrophils were analyzed by ﬂow cytometry. The plotted data rep-
resent three independent experiments. (C) BMcells fromC57BL/6micewere culturedwithG-CSF (100 ng/mL) in the presence of either super-lowdose (100pg/mL) or lowdose (1 μg/mL) LPS
for 3 days, and fresh LPS was added to the cell cultures every 24 h. After stimulation with PMA (50 nM) for 3 h, the levels of histone H4 (citrulline 3) within CD11b+/Ly6G+ neutrophils
were analyzed by ﬂow cytometry. Quantitative data were shown as means ± SEM from three independently treated samples. Asterisks indicate statistically signiﬁcant differences com-
pared between indicated groups (*, p b 0.05; ***, p b 0.001).
Fig. 5.Differentialmodulations of JNK and ERKphosphorylation by super-low and lowdose LPS contribute to dynamic regulation of NET formation. Bonemarrow (BM) cells fromC57 BL/6
mice were cultured with G-CSF (100 ng/mL) in the presence of either super-low dose (100 pg/mL) or low dose (1 μg/mL) LPS. The phosphorylation levels of JNK (T183/Y185) or ERK1/2
(T204/Y202)within CD11b+/Ly6G+ neutrophils were analyzed by ﬂow cytometry after 3 d or 3 h respectively. Quantitative data were shown asmeans± SEM from three independently
treated samples. Asterisks indicate statistically signiﬁcant differences compared between indicated groups (**, p b 0.01; ***, p b 0.001).
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Fig. 6. TUDCA restores ERK phosphorylation, NET formation in neutrophils treated with super-low dose LPS. (A) BM cells were culturedwith G-CSF (100 ng/mL) in the presence of either
super-lowdose (100pg/mL) or lowdose (1 μg/mL) LPS. Some cellswere also treatedwith TUDCA (0.5mM). The phosphorylation levels of JNK (T183/Y185) or ERK1/2 (T204/Y202)within
CD11b+/Ly6G+ neutrophils were analyzed by ﬂow cytometry after 3 d or 3 h respectively. (B) BM cells were cultured with G-CSF (100 ng/mL) in the presence of either super-low dose
(100 pg/mL) or low dose (1 μg/mL) LPS for 3 days, and some cells were also treated with TUDCA (0.5 mM). After stimulationwith PMA (50 nM) for 3 h, the levels of histone H4 (citrulline
3) within CD11b+/Ly6G+ neutrophils were analyzed by ﬂow cytometry. Quantitative data were shown as means ± SEM from three independently treated samples. Asterisks indicate
statistically signiﬁcant differences compared between the indicated groups (*, p b 0.05; **, p b 0.01; ***, p b 0.001).
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(Stearns-Kurosawa et al., 2011). Neutrophils have multiple functions
that include cytokine expression, degranulation, suppression of T cells,
and NET formation (Mayadas et al., 2014). Although the dynamic pre-
conditioning ofmonocytes by varying dosages of LPS is recently noticed,Fig. 7. An illustrative diagram summarizing the dynamic programming of neutrophils by
super-low dose LPS. Low dose LPS activates ERK and neutrophil NET formation. Together
with other tolerant effects in other cells such as monocytes/macrophages, low dose LPS
pre-conditioning offers protection to subsequent sepsis challenge. In contrast, this work
reveals that super-lowdose LPS signiﬁcantly suppresses ERKandNET formation inneutro-
phils. This dynamic switch in signalingmay exacerbate sepsismortality. Restoration of this
switch may serve as a potential future therapeutic target for the prevention or treatment
of sepsis.no information is available regarding the dynamic responses of neutro-
phils in this context. Our current study ﬁlls this critical void and reveals
intriguing dynamics of neutrophils when challenged with varying dos-
ages of LPS.We particularly focused on neutrophil NET and revealed op-
posing behaviors of NET generation in neutrophils pre-conditioned
with super-low and low dose LPS. Our current work offers a glimpse
of neutrophil dynamics pre-conditioned with varying dosages of LPS,
and begets future systems studies about the complex programming of
neutrophils in health and disease. Furthermore, or data suggest that
differential pre-conditioning of neutrophils may be harnessed for the
effective treatment of sepsis.
In terms of underlying molecular mechanisms, our study eludes to
the functional signiﬁcance of mutually inhibitory circuits in ﬁne-
tuning leukocyte responses. Traditional studies overly simpliﬁed the
signaling systems into cascades of events that bynomeans can reconcile
the complex dynamics of living systems. Instead, emerging studies from
other systems emphasize the necessity of mutually inhibitory circuits
required for complex cellular outcomes (Tyson et al., 2001). This may
enable organisms highly coordinated adaptation to changing environ-
ments. We reported dynamic circuits that are responsible for the prim-
ing and tolerance phenotypes in monocytes/macrophages challenged
with varying dosages of LPS (Fu et al., 2012; Maitra et al., 2012).
Similarly-wired circuits also exist in T Helper cells, responsible for the
dynamic differentiation into a plethora of T helper cells (Hong et al.,
2011). JNK and ERK may constitute a mutually inhibitory circuits
based on previous studies (Arany et al., 2004; Bakal et al., 2008;
332 K. Chen et al. / EBioMedicine 2 (2015) 324–333Junttila et al., 2008; Shen et al., 2003). In this current study, we observed
that super-low dose LPS selectively suppresses ERK and favors JNK acti-
vation in neutrophils. Furthermore, suppression of ERK by super-low
dose LPS correlates with suppressed neutrophil NET formation and re-
duced bacterial killing activity. In contrast, higher dose LPS may ﬂip
this circuit, induces ERK and NET formation. Mechanisms responsible
for the competitive regulation of ERK and JNK are not clear, andwarrant
future studies. One possible scenario may be the competitive regulation
of opposingMAP kinase phosphatases (MKPs). A recent study indicates
that the varying signal strength of CD40 ligand may differentially
activate either MKP1 (a selective JNK and p38 phosphatase) or MKP3
(a selective EKR phosphatase) (Srivastava et al., 2011). Further compre-
hension of the dynamic circuits within innate leukocytes is clearly war-
ranted. Capitalizing on this initial ﬁnding, we attempted at re-balancing
the skewed circuit in neutrophils with a promising drug TUDCA. We
demonstrate that TUDCA can restore ERK activation in the presence of
super-low dose LPS, as well as the NET formation in neutrophils. This
attempt raises an intriguing potential for the future treatment of sepsis
through re-balancing network dynamics in leukocytes. Supporting
this concept, a recent study suggests that pre-conditioning with an
un-conventional TLR2 agonist may render a broader protection toward
viral infection (Shirey et al., 2013).
Taken together, our data reveal dynamics of innate pre-conditioning
by SL-LPS in the context of sepsis, and provide amechanism for differen-
tial modulation of neutrophil NET formation by SL-LPS. Our work also
serves as a prelude to a daunting task in further deﬁning the emerging
concept of innate immunity programming and memory in health and
disease. At the translational level, our study suggests that strategies
aimed at re-balancing the innate immunity dynamicsmay hold promise
in the prevention and/or treatment of severe sepsis.
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